An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...

Oncuria-Detect and EarlyTect BCD Plus assays may promote earlier detection of bladder cancer following hematuria. When hematuria is emergent, prompt investigation and diagnosis can be lifesaving. The ...

Partnership marks the first introduction of Shield™ multi-cancer detection test in the region with availability across Hong Kong, Singapore and the Philippines Eligible Manulife customers in Hong Kong ...

A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...

Shares of Grail lost more than half their value on Friday, after a key trial of the company’s cancer screener failed to meet its primary objective. The stock’s GRAL plunge reflected the disappointment ...

Multicancer blood tests have for years been hyped as a potential breakthrough in early cancer detection. But with news that one of the big names in the field, the Galleri test, failed to meet its ...

Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...

The company will offer access to Galleri®, an innovative blood test from GRAIL, Inc. that screens for more than 50 types of cancer Today, Hims & Hers Health, Inc. (NYSE: HIMS), the leading digital ...

Jan 20 (Reuters) - Bristol Myers Squibb (BMY.N), opens new tab said on Tuesday it had signed an agreement with Microsoft (MSFT.O), opens new tab to use the tech company's AI-enabled radiology platform ...

(RTTNews) - Bristol Myers Squibb Co. (BMY), on Tuesday announced that it has entered into an agreement with Microsoft Corp. (MSFT) to accelerate the early detection of lung cancer through the ...

This repository provides code and workflows to test several state-of-the-art vehicle detection deep learning algorithms —including YOLOX, SalsaNext, and RandLA-Net— on a Flash Lidar dataset. The ...

The tests have not been approved by federal regulators, but that hasn’t stopped patients from wanting them — and doctors from worrying. By Nina Agrawal In the spring of 2021, the cancer field was ...